Single Biggest Cancer Dictionary in the World

What is

STING agonist GSK3745417

?

Pronunciation: /stɪŋ ˈægənɪst gsk* θri ˈmɪljən, ˈsɛvən ˈhənərd ənd ˈfɔrtiˌfaɪv ˈθaʊzənd, fɔr ˈhənərd ənd ˈsɛvənˈtin/

STING agonist GSK3745417

Definition

An agonist of the stimulator of interferon genes protein (STING; transmembrane protein 173; TMEM173), with potential immunoactivating and antineoplastic activities. Upon intravenous administration, STING agonist GSK3745417 targets and binds to STING and activates the STING pathway in immune cells in the tumor microenvironment (TME). This leads to the production of pro-inflammatory cytokines, including interferons (IFNs), enhances the cross-presentation of tumor-associated antigens (TAAs) by dendritic cells (DCs), and induces a cytotoxic T-lymphocyte (CTL)-mediated immune response against cancer cells. STING, a transmembrane protein that activates immune cells in the TME, plays a key role in the activation of the innate immune system.